(Q80258993)
Statements
A phase II study of bortezomib in mantle cell lymphoma: the National Cancer Institute of Canada Clinical Trials Group trial IND.150 (English)
A Belch
C T Kouroukis
M Crump
L Sehn
R D Gascoyne
R Klasa
J Powers
J Wright
E A Eisenhauer
13 September 2006